NZ204965A - Antibiotic bbm-1644 and pharmaceutical compositions - Google Patents

Antibiotic bbm-1644 and pharmaceutical compositions

Info

Publication number
NZ204965A
NZ204965A NZ204965A NZ20496583A NZ204965A NZ 204965 A NZ204965 A NZ 204965A NZ 204965 A NZ204965 A NZ 204965A NZ 20496583 A NZ20496583 A NZ 20496583A NZ 204965 A NZ204965 A NZ 204965A
Authority
NZ
New Zealand
Prior art keywords
bbm
antibiotic
agar
inhibiting
effective
Prior art date
Application number
NZ204965A
Other languages
English (en)
Inventor
M Konishi
F Sakai
T Miyaki
H Kawaguchi
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ204965A publication Critical patent/NZ204965A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/825—Actinomadura

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ204965A 1982-07-26 1983-07-20 Antibiotic bbm-1644 and pharmaceutical compositions NZ204965A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40146882A 1982-07-26 1982-07-26

Publications (1)

Publication Number Publication Date
NZ204965A true NZ204965A (en) 1986-09-10

Family

ID=23587892

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ204965A NZ204965A (en) 1982-07-26 1983-07-20 Antibiotic bbm-1644 and pharmaceutical compositions

Country Status (29)

Country Link
JP (1) JPS5948084A (enEXAMPLES)
KR (1) KR840005484A (enEXAMPLES)
AU (1) AU567105B2 (enEXAMPLES)
BE (1) BE897381A (enEXAMPLES)
CA (1) CA1215337A (enEXAMPLES)
CH (1) CH657778A5 (enEXAMPLES)
CS (1) CS251077B2 (enEXAMPLES)
DD (1) DD210075A5 (enEXAMPLES)
DE (1) DE3326917A1 (enEXAMPLES)
DK (1) DK339683A (enEXAMPLES)
ES (1) ES524405A0 (enEXAMPLES)
FI (1) FI832676L (enEXAMPLES)
FR (1) FR2530663A1 (enEXAMPLES)
GB (1) GB2124234B (enEXAMPLES)
GR (1) GR78648B (enEXAMPLES)
HU (1) HU192165B (enEXAMPLES)
IE (1) IE55800B1 (enEXAMPLES)
IL (1) IL69313A0 (enEXAMPLES)
IT (1) IT1163847B (enEXAMPLES)
LU (1) LU84930A1 (enEXAMPLES)
MY (1) MY8800125A (enEXAMPLES)
NL (1) NL8302610A (enEXAMPLES)
NO (1) NO832689L (enEXAMPLES)
NZ (1) NZ204965A (enEXAMPLES)
OA (1) OA07503A (enEXAMPLES)
PT (1) PT77091B (enEXAMPLES)
SE (1) SE8304132L (enEXAMPLES)
YU (1) YU158583A (enEXAMPLES)
ZA (1) ZA835337B (enEXAMPLES)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
JPS606194A (ja) * 1983-06-23 1985-01-12 Meiji Seika Kaisha Ltd 新規抗生物質ｓｆ−２２８８及びその製造法
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex
US5304373A (en) * 1991-10-22 1994-04-19 Bristol-Myers Squibb Co. Antitumor antibiotic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148882A (en) * 1977-06-24 1979-04-10 Pfizer Inc. Polycyclic ether antibiotics produced by new species of actinomycete
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
CA1198386A (en) * 1981-10-22 1985-12-24 Donald B. Borders ANTIBACTERIAL AGENTS LL-C23024.beta. AND IOTA AND MICROORGANISM ACTINOMADURA YUMAENSE NRRL 12515
US4578271A (en) * 1982-05-24 1986-03-25 Fujisawa Pharmaceutical Co., Ltd. Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
NZ208013A (en) * 1983-05-16 1987-07-31 Bristol Myers Co Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora

Also Published As

Publication number Publication date
ES8502161A1 (es) 1984-12-16
ZA835337B (en) 1984-03-28
IE55800B1 (en) 1991-01-16
BE897381A (fr) 1984-01-26
SE8304132D0 (sv) 1983-07-25
ES524405A0 (es) 1984-12-16
IE831740L (en) 1984-01-26
NO832689L (no) 1984-01-27
YU158583A (en) 1985-12-31
PT77091B (en) 1986-06-26
DD210075A5 (de) 1984-05-30
HUT37167A (en) 1985-11-28
DE3326917A1 (de) 1984-02-02
GB2124234B (en) 1986-04-03
KR840005484A (ko) 1984-11-14
FR2530663A1 (fr) 1984-01-27
GB8320026D0 (en) 1983-08-24
IL69313A0 (en) 1983-11-30
GB2124234A (en) 1984-02-15
DK339683A (da) 1984-01-27
IT8322219A0 (it) 1983-07-25
HU192165B (en) 1987-05-28
CA1215337A (en) 1986-12-16
CS251077B2 (en) 1987-06-11
SE8304132L (sv) 1984-01-27
MY8800125A (en) 1988-12-31
JPH0526799B2 (enEXAMPLES) 1993-04-19
DK339683D0 (da) 1983-07-25
CH657778A5 (de) 1986-09-30
NL8302610A (nl) 1984-02-16
OA07503A (en) 1985-03-31
LU84930A1 (fr) 1984-03-22
PT77091A (en) 1983-08-01
FI832676A0 (fi) 1983-07-22
IT1163847B (it) 1987-04-08
AU567105B2 (en) 1987-11-12
JPS5948084A (ja) 1984-03-19
GR78648B (enEXAMPLES) 1984-09-27
FI832676A7 (fi) 1984-01-27
AU1720083A (en) 1984-02-02
FI832676L (fi) 1984-01-27

Similar Documents

Publication Publication Date Title
HANADA et al. Maduropeptin, a complex of new macromolecular antitumor antibiotics
US4328316A (en) Biologically pure culture of actinoplanes capable of producing antibiotic A/16686
US4754018A (en) Antibiotic prepared from lysobacter sp. SC 14,067 and analogs thereof
JPH0637508B2 (ja) 抗生物質Ａ４０９２６複合体およびその純粋な因子ＰＡ、ＰＢ、Ａ、ＢおよびＢｏ
CA1209935A (en) Biologically active ws 6049 substances, a process for the production thereof and their pharmaceutical compositions
US4971965A (en) Antibiotics TAN-1057
IE52026B1 (en) Antibiotic a/16686 factor a2,the process for the preparation thereof,and the co-produced antibiotic a/16686 factors a1 and a3
US4546084A (en) Biologically pure culture of Actinomadura Sp.
CA1215337A (en) Antitumor antibiotic
KOMORI et al. LAVENDOMYCIN, A NEW ANTIBIOTIC I. TAXONOMY, ISOLATION AND CHARACTERIZATION
CA1158999A (en) Istamycins and production thereof
US4051237A (en) Glycopeptide antibiotics bu-2231 a and b and process for producing same
US4764602A (en) Antibiotics, and their production
US4804534A (en) Antibiotic A 42867 and the addition salts thereof
Katayama et al. SPERABILLINS, NEW ANTIBACTERIAL ANTIBIOTICS WITH POTENT IN VIVO ACTIVITY TAXONOMY, FERMENTATION, ISOLATION AND BIOLOGICAL ACTIVITY
US4656288A (en) Antibiotics, their production and use
US4677071A (en) Antibiotic agents from S. coeruleorubidus, rubidus
Otani et al. C-1027-AG, a selective antagonist of the macromolecular antitumor antibiotic, C-1027
US4499075A (en) Antibiotic agents from S. coeruleorubidus, rubidus
US4560748A (en) Streptothricin-group compounds
US4816559A (en) Biologically active peptides TAN-866
US4463092A (en) Process for production antibiotic A53868
US4317812A (en) Polynitroxin antibiotics produced by Nocardiopsis mutabilis Shearer sp. nov. ATCC 31520
US5165931A (en) Peptifluorin and neopeptifluorin
US4482488A (en) Antibiotic A53868 and process for production thereof